乳酸相关指标与脓毒症关系的研究进展
本文为综述,聚焦乳酰化、乳酸化、乳酸相关指标与脓毒症的关系及最新研究进展。脓毒症仍是全球危重症患者高死亡率的主要原因,早期诊断、及时治疗与准确预测预后对成功治疗至关重要。乳酸不仅作为脓毒性休克的诊断指标,还参与脓毒症免疫反应过程,通过乳酰化调控基因表观遗传,影响相关基因表达、细胞代谢与机体免疫反应,可能成为脓毒症治疗新靶点。乳酸相关指标如乳酸/白蛋白比值(LAR)与乳酸/血细胞比容比值(LHR)在脓毒症患者预后评估中具有重要价值,且优于单一指标的评估效能,有助于及时发现病情变化、风险分层与精准治疗。
要点
- 乳酸不仅作为脓毒性休克的诊断指标,还参与脓毒症免疫反应,通过乳酰化调控基因表观遗传,影响基因表达、细胞代谢与机体免疫反应。
- 乳酰化可能成为脓毒症治疗的新靶点。
- 乳酸相关指标如乳酸/白蛋白比值(LAR)与乳酸/血细胞比容比值(LHR)在脓毒症患者预后评估中具有重要价值。
- LAR与LHR对脓毒症患者的预后评估效能优于单一指标的评估效能。
- 上述指标有助于及时发现脓毒症患者病情变化、进行风险分层与精准治疗。
适用人群与场景
- 脓毒症患者,用于预后评估与风险分层。
研究设计与关键结果
- 本文为综述,聚焦乳酰化、乳酸化、乳酸相关指标与脓毒症的关系及最新研究进展。
- 乳酸通过乳酰化调控基因表观遗传,影响相关基因表达、细胞代谢与机体免疫反应,可能成为脓毒症治疗新靶点。
- 乳酸/白蛋白比值(LAR)与乳酸/血细胞比容比值(LHR)在脓毒症患者预后评估中具有重要价值,且优于单一指标的评估效能。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,乳酸相关指标(LAR、LHR)有助于及时发现脓毒症患者病情变化、进行风险分层与精准治疗。
- 作者认为,乳酰化可能成为脓毒症治疗的新靶点,为临床诊断与治疗提供新思路。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
In recent years, significant progress has been made in the study of the complex pathophysiology of sepsis. However, sepsis remains the main cause of high mortality among critically ill patients worldwide. Early diagnosis, timely treatment, and accurate prediction of the prognosis are crucial for the successful treatment of septic patients. Lactic acid not only serves as a diagnostic indicator for septic shock but also participates in the immune response process of sepsis. It regulates gene epigenetic regulation through lactylation, thereby affecting the expression of related genes, cellular metabolism, and the immune response of the body. Therefore, it may become a new target for the treatment of sepsis. Lactate-related indicators, such as lactic acid/albumin ratio (LAR) and lactic acid/hematocrit ratio (LHR), also have important value in the prognosis assessment of septic patients and are superior to the evaluation efficacy of a single indicator. This is of great significance for timely detection of the changes in the condition of septic patients and their risk stratification and precise treatment. This review focused on the relationship between lactylation, lactatization, lactate-related indicators and sepsis, as well as the latest research progress. By revealing their roles in the occurrence, development and prognosis of sepsis, it provided new ideas for clinical diagnosis and treatment, uncovered new mechanisms of disease onset, guided disease risk stratification, optimized existing treatment strategies, and also offered new references and directions for basic research on lactate-related indicators.
参考来源
- Liu Y, Li W, Huang L, et al. [Research progress on the relationship between lactate-related indicators and sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 41331894. doi:10.3760/cma.j.cn121430-20250708-00645
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。